Question 1

Why are embryonic and induced pluripotent stem cells useful for disease research?

Accepted Answer

EPS and iPS cells can divide indefinitely without differentiating and differentiate into most body cell types when stimulated. These properties make them ideal for disease modeling, where cells simulate specific diseases, and for drug screening. Unlike animal models, patient-derived cells replicate human physiology and disease phenotypes accurately.

Question 2

How are iPS cells created from patient cells for disease modeling?

Accepted Answer

Somatic cells from a patient are isolated and reprogrammed into induced pluripotent stem cells through somatic to ips cell reprogramming. These iPSCs are then differentiated into the desired cell type that mirrors the patient's diseased cells, enabling researchers to study disease mechanisms and identify disease-causing mutations.

Question 3

What advantages do patient-derived iPSCs offer over animal models for drug testing?

Accepted Answer

Patient-derived iPSCs have the same genetic makeup as the patient's disease-affected cells and can replicate diseased tissue physiology accurately. Animal models are expensive, raise ethical concerns, and may not mirror human disease. iPSCs enable pre-clinical drug screening for toxicity and efficacy before human clinical trials.

Question 4

How can iPS cells help researchers understand Parkinson's disease?

Accepted Answer

Fibroblasts from Parkinson's disease patients are reprogrammed into iPS cells, which differentiate into specific midbrain neurons. These neurons allow scientists to identify mutations causing the disease and understand disease mechanisms that cannot be studied using damaged patient neurons directly. This approach enables targeted investigation of neurodegenerative pathways.

Question 5

What diseases have been modeled using patient-derived iPSCs?

Accepted Answer

Disease models created from iPSCs include Down syndrome, type I diabetes, and spinal muscular atrophy. These models allow researchers to investigate disease mechanisms and test treatments. Currently, drugs for cardiovascular, neurodegenerative, and liver disorders are being tested using iPSC-derived cells in pre-clinical studies.

Question 6

How do iPSCs maintain their ability to differentiate into multiple cell types?

Accepted Answer

iPSCs maintain pluripotency through chromatin modification in ips cells, which regulates gene expression and allows self-renewal. This epigenetic regulation enables iPSCs to remain undifferentiated until stimulated, preserving their capacity to differentiate into most body cell types for research applications and disease modeling.

Question 7

What information can drug screening with iPSCs provide before clinical trials?

Accepted Answer

iPSC-derived cells enable researchers to screen drugs for their effects, toxicity at varying doses, and patient-specific responses. This pre-clinical testing identifies promising drug candidates and potential safety concerns before medicines are tested directly in humans during clinical trials, reducing development costs and ethical concerns.

EPS and iPS Cells in Disease Research

Browse More Videos